Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 22974393)

1.

Proteomic classification of breast cancer.

Kamel D, Brady B, Tabchy A, Mills GB, Hennessy B.

Curr Drug Targets. 2012 Nov;13(12):1495-509. Review.

PMID:
22974393
2.

Breast cancer proteomics: a review for clinicians.

Galvão ER, Martins LM, Ibiapina JO, Andrade HM, Monte SJ.

J Cancer Res Clin Oncol. 2011 Jun;137(6):915-25. doi: 10.1007/s00432-011-0978-0. Epub 2011 Apr 5. Review.

PMID:
21465318
3.

Quantitative proteomic analysis in breast cancer.

Tabchy A, Hennessy BT, Gonzalez-Angulo AM, Bernstam FM, Lu Y, Mills GB.

Drugs Today (Barc). 2011 Feb;47(2):169-82. doi: 10.1358/dot.2011.47.2.1576695.

PMID:
21431104
4.

Protein expression profile and prevalence pattern of the molecular classes of breast cancer--a Saudi population based study.

Al Tamimi DM, Shawarby MA, Ahmed A, Hassan AK, AlOdaini AA.

BMC Cancer. 2010 May 21;10:223. doi: 10.1186/1471-2407-10-223.

5.

Tumor proteomic profiling predicts the susceptibility of breast cancer to chemotherapy.

He J, Shen D, Chung DU, Saxton RE, Whitelegge JP, Faull KF, Chang HR.

Int J Oncol. 2009 Oct;35(4):683-92.

PMID:
19724903
6.

Proteomics of breast carcinoma.

Somiari RI, Somiari S, Russell S, Shriver CD.

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Feb 5;815(1-2):215-25. Review.

PMID:
15652811
7.

[Proteomics and breast cancer: a search for novel diagnostic and theragnostic biomarkers].

Gilabert M, Audebert S, Viens P, Borg JP, Bertucci F, Gonçalves A.

Bull Cancer. 2010 Mar;97(3):321-39. doi: 10.1684/bdc.2010.1061. Review. French.

PMID:
20202919
8.

Implications of functional proteomics in breast cancer.

Chae YK, Gonzalez-Angulo AM.

Oncologist. 2014 Apr;19(4):328-35. doi: 10.1634/theoncologist.2013-0437. Epub 2014 Mar 24. Review.

9.

Proteomic analysis of tissue samples in translational breast cancer research.

Gromov P, Moreira JM, Gromova I.

Expert Rev Proteomics. 2014 Jun;11(3):285-302. doi: 10.1586/14789450.2014.899469. Epub 2014 Mar 20. Review.

PMID:
24837673
10.

Proteomic portrait of human breast cancer progression identifies novel prognostic markers.

Geiger T, Madden SF, Gallagher WM, Cox J, Mann M.

Cancer Res. 2012 May 1;72(9):2428-39. doi: 10.1158/0008-5472.CAN-11-3711. Epub 2012 Mar 13.

11.

Tissue biomarkers of breast cancer and their association with conventional pathologic features.

Chung L, Shibli S, Moore K, Elder EE, Boyle FM, Marsh DJ, Baxter RC.

Br J Cancer. 2013 Feb 5;108(2):351-60. doi: 10.1038/bjc.2012.552. Epub 2013 Jan 8.

12.

How many etiological subtypes of breast cancer: two, three, four, or more?

Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME.

J Natl Cancer Inst. 2014 Aug 12;106(8). pii: dju165. doi: 10.1093/jnci/dju165. Print 2014 Aug. Review.

13.

Mixture classification model based on clinical markers for breast cancer prognosis.

Zeng T, Liu J.

Artif Intell Med. 2010 Feb-Mar;48(2-3):129-37. doi: 10.1016/j.artmed.2009.07.008. Epub 2009 Dec 14.

PMID:
20005686
14.

Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.

Hodgkinson VC, Eagle GL, Drew PJ, Lind MJ, Cawkwell L.

Cancer Lett. 2010 Aug 1;294(1):13-24. doi: 10.1016/j.canlet.2010.01.036. Epub 2010 Feb 21. Review.

PMID:
20176436
15.

Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT).

Chen EI, Hewel J, Felding-Habermann B, Yates JR 3rd.

Mol Cell Proteomics. 2006 Jan;5(1):53-6. Epub 2005 Nov 4.

16.

The pS2 gene, mRNA, and protein: a potential marker for human breast cancer.

Rio MC, Chambon P.

Cancer Cells. 1990 Aug-Sep;2(8-9):269-74. Review.

PMID:
2223388
17.

Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.

Lai TC, Chou HC, Chen YW, Lee TR, Chan HT, Shen HH, Lee WT, Lin ST, Lu YC, Wu CL, Chan HL.

J Proteome Res. 2010 Mar 5;9(3):1302-22. doi: 10.1021/pr900825t.

PMID:
20052998
18.

Prognostic molecular markers in early breast cancer.

Esteva FJ, Hortobagyi GN.

Breast Cancer Res. 2004;6(3):109-18. Epub 2004 Mar 11. Review.

19.

Proteomic evaluation of core biopsy specimens from breast lesions.

Bisca A, D'Ambrosio C, Scaloni A, Puglisi F, Aprile G, Piga A, Zuiani C, Bazzocchi M, Di Loreto C, Paron I, Tell G, Damante G.

Cancer Lett. 2004 Feb 10;204(1):79-86.

PMID:
14744537
20.

Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium.

Hudelist G, Singer CF, Pischinger KI, Kaserer K, Manavi M, Kubista E, Czerwenka KF.

Proteomics. 2006 Mar;6(6):1989-2002.

PMID:
16470630
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk